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Abstract 
Collagen implants are widely used in clinical practice and are an active area of 
research.  The continued development of collagen-based implants often relies on 
histological techniques to fully evaluate the host response post implantation.  These 
destructive, end-point analyses limit the rate that data can be obtained from samples.  
Magnetic resonance imaging has the potential to non-invasively monitor the remodeling 
of collagen scaffolds.  In this study, scaffolds prepared from insoluble bovine collagen, 
with varied and predictable tissue responses were implanted in rats and evaluated using 
both histological and MRI techniques.  Treatment of scaffolds with a carbodiimide 
crosslinker was found to slow the degradation and cellular infiltration into the scaffolds 
compared to uncrosslinked scaffolds.  Angiogenesis was observed in core regions of 
crosslinked scaffolds, but not uncrosslinked scaffolds.  Conjugation of chondroitin sulfate 
to the collagen scaffolds in combination with crosslinking improved both the cellular 
infiltration and angiogenesis compared to uncrosslinked and crosslinked scaffolds.  
Correlations between histology and MRI analyses showed that statistically significant 
relationships existed between cellular density, void area, T2 and apparent diffusion 
coefficient (ADC) measurements demonstrating that MRI is sensitive to specific 
remodeling parameters.  Understanding the relationship between histology and MRI 
parameters may be used to help guide the interpretation of MRI data as well as to reliably 
detect changes within the implants using the MRI data alone, reducing the need for 
scaffold harvesting and destructive testing. 
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1 Introduction 
Medical technology to repair or replace damaged tissues has been greatly 
influenced by the emergence of tissue engineering and regenerative medicine.  Implants 
that enhance the healing process, by providing a provisional cell scaffold have become a 
significant focus of biomedical research and an active area of research. 
The continued improvement of implantable tissue engineering devices depends on 
the ability to collect relevant data to assess the performance of the implant.  During the 
development of implants, researchers and clinicians must evaluate the functionality of the 
implant and the surrounding tissue response.  Current data collection methods to evaluate 
critical parameters of implant performance are commonly limited by invasive techniques, 
such as histological analyses of explants.  These destructive, end-point analyses limit the 
rate that data can be obtained from samples and increase the degree of statistical error 
associated with sample to sample variability in time course studies. 
Magnetic Resonance Imaging (MRI) has become an indispensable diagnostic tool 
in the clinical setting for characterizing pathologies, such as stroke[1] and tumors,[2] due to 
its sensitivity to changes in water content and the particular water environment.  This tool 
is used to monitor soft tissues by measuring vascularity, cellularity and water diffusion.  
We hypothesize that MRI can be used as an enabling technology to monitor and assess 
implants and to facilitate high-throughput analysis of tissue engineered devices, by 
noninvasively providing the same information as histological techniques.  This would 
provide researchers the ability to study implants without having to destroy them. 
Collagen is a widely used implant biomaterial used in many tissue engineering 
devices.  Artificial skin equivalents[3, 4] vascular grafts,[5] meniscus repairs,[6] drug 
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delivery devices[7] are all research areas where the possibility of using collagen is being 
explored, or where actual collagen-based devices are available on the market and in 
clinical use.  The highly conserved structure of collagen across species, which gives rise 
to its inherent biocompatibility, as well as its tolerance for certain manufacturing 
techniques, makes collagen a widely used biomaterial and a natural choice for this study. 
The current methods for evaluating implants, in the majority of cases reported in 
the literature, rely on predefined, semi-quantitative scales.  Blinded pathologists score 
tissue sections using a pre-defined scale for parameters that are relevant to the particular 
study.  This usually includes parameters such as the relative numbers of cells and their 
type, the foreign body reaction, angiogenesis within the implant and area of affected 
tissue surrounding the implant.  These measurements provide an easy metric to compare 
the relative differences in tissue response between types of implants but are difficult to 
correlate with MRI measurements because the scale is usually arbitrary.  For this study 
quantitative histological techniques were developed to avoid the use of pre-defined 
scales. 
In this study, scaffolds with varied and predictable responses were implanted 
subcutaneously in rats and evaluated using quantitative histological techniques to 
characterize the tissue response.  Concurrently, implants were imaged using MRI to 
observe changes in these data with increasing implantation time.  Histological 
measurements were correlated with MRI data to determine which parameters provide the 
best assessment of the implant in terms of degradation, cellular density and angiogenesis. 
A wide range of tissue responses were observed by measuring changes in cellular 
density, blood vessel density and void areas based on differences in crosslinking 
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treatment.  Statistically significant correlations between the histology and MRI data were 
found, showing that MRI can indeed be used to monitor changes within the collagen 
scaffolds. 
The correlation data will be used to help guide the interpretation of future MRI 
data so that studies may be able to reliably detect changes within the implants using the 
MRI data alone, reducing the need for scaffold harvesting.  Understanding the 
relationship between histology and MRI parameters will eventually allow for the 
monitoring of implants in a clinical setting, preventing unnecessary surgical revisions or 
alerting clinicians that a change in treatment is required before complete failure of the 
implant. 
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2 Background 
The development of a noninvasive technique to monitor collagen scaffold 
implants requires an understanding of the implants, their interactions with the 
surrounding tissue, and the proposed imaging modalities.  Selected methods to form the 
initial shape and structure of the implant as well as the methods used to biochemically 
tailor the implant for specific applications are reviewed to provide an understanding of 
the nature of the implant.  The biological responses to implantation and the methods used 
to evaluate the implants are also discussed.  Finally, the fundamental physics of MRI that 
give rise to the various parameters is briefly presented to provide an understanding of the 
underlying principles.  Previous MRI studies to evaluate implants and their results are 
also presented. 
2.1 Collagen Matrix Fabrication 
Collagen is well documented as a biomaterial for medical applications.  Collagen 
implants are used for medical devices for applications including drug delivery, wound 
dressings, tissue and bone fillings, dental repair, and vascular defects.[8,9,7,10,11]  Part of 
collagen’s wide applicability is due to the many forms that collagen can be crafted into 
and its excellent biocompatibility.  As a major component of the extracellular matrix 
(ECM) in higher mammals, cells recognize and respond to the biochemical surface 
features of collagen in a manner that closely emulates a native wound healing response.  
Furthermore, these biochemical features can be modified to suit the specific application 
either by incorporating biologically active molecules or by chemically modifying the 
implant.  The material is easily remodeled and integrated into the surrounding tissue via 
native enzymatic pathways, followed by new collagen synthesis by the host.  Collagen 
 4
scaffolds are of particular interest because of their suitability as cell-based scaffolds.[12]  
In addition to the biochemical benefits of collagen, the physical structure of scaffolds can 
be controlled to suit particular applications.  The high void volume and interconnected 
pore structure provide space for cellular infiltration and transport of nutrients and waste 
through the scaffold.[9]  For example, to create functional dermal analogs, scaffolds must 
be fabricated with average pores sizes between 20 and 125 μm.[13]  Additionally, collagen 
is readily available from many natural sources. 
2.1.1 Lyophilization 
Many techniques have been developed to control the size of the pores and to 
achieve the inter-connected pore structure necessary for cellular infiltration and mass 
transport within implantable scaffolds.  These include solvent-casting, particulate-
leaching, gas foaming, phase separation, fiber meshes/fiber bonding, melt molding and 
freeze drying.[14]  However, with the exception of gas foaming and freeze drying, these 
techniques require harsh organic solvents that limit their use to the fabrication of 
synthetic materials.  These techniques also create closed or dead-end pores rather than the 
desired interconnected pore structure.  Collagen scaffolds are most commonly prepared 
using a freeze drying, or lyophilization, process. 
Freeze drying is performed by freezing a dispersion of insoluble collagen 
prepared in a weakly acidic solution.  The formation of ice crystals forces collagen to 
localize between the crystals creating an interpenetrating network of collagen and ice 
crystals.  The ice is then sublimated, leaving behind a pore structure that mirrors the ice 
formation.[15]  Controlling the freezing conditions allows the pore organization to be 
precisely controlled.[15,16]  During the freezing process the thermal gradients within the 
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scaffolds lead to distinct freezing lines, particularly on the side of the scaffold not 
exposed to the atmosphere, sometimes referred to as the “pan-side.”  These freezing lines 
are oriented by the thermal gradient.  The situation is further complicated by changes in 
thermal gradients as the temperature of the dispersion changes.  These cause changes in 
the orientation of the freezing lines and also contribute to the heterogeneity in the 
scaffold. 
An additional source of scaffold heterogeneity is the creation of a 
morphologically distinct “skin” layer at the surface of the sponge exposed to the 
surrounding atmosphere.  This layer develops due to greater solvent evaporation at the 
dispersion-air interface than within the dispersion.[17]  The greater concentration of 
collagen at the surface creates pore sizes that are generally smaller compared to pores 
found deeper in the sponge.  This layer of different pore sizes effects mass transport 
through the sponge as well as cellular attachment and infiltration.[15]  Careful attention 
will need to be given to these processes to ensure the sponges are created with 
biologically functional pore sizes.  For these studies, the scaffolds should be as 
homogenous as possible to simplify the analyses. 
2.1.2 Crosslinking 
In addition to manipulating the physical structure of sponges, chemical techniques 
have been developed to enhance the degradation rate and the biofunctionality of sponges 
to further tailor them to specific applications through biochemical modifications. 
The particular environment into which the sponge will be implanted can vary 
greatly.  For example, in a burn wound where a collagen sponge would be used as a skin 
graft, there are high concentrations of proteolytic enzymes.[18]  These enzymes degrade 
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the sponge faster than if the sponge is placed in a bony defect to guide osteoblast activity.  
It is often the case that the collagen is degraded faster than would be desired for optimal 
healing due to the fact that collagen is prevalent in the body and therefore susceptible to a 
large number of enzymes that efficiently degrade foreign material.  Various techniques 
have been developed to modify collagen sponges so that their resistance to degradation is 
appropriate for the particular implant environment or application.  The most common 
method for increasing the degradation resistance of scaffolds is to introduce additional 
chemical bonds between the collagen molecules, termed crosslinks.  Similarly, the tensile 
strength of the sponge and other mechanical properties can be increased by crosslinking.  
Crosslinking also believed to reduce the immunogenicity of the collagen by masking 
certain antigens, allowing for xenogenic collagen to be implanted without causing a 
chronic immune response.[19]  These bonds can be formed using physical or chemical 
strategies.  Physical methods do not introduce exogenous chemicals that may remain 
within the scaffold and detrimentally influence the biological response post-implantation.  
However, the degree of crosslinking can be challenging to control, and other effects, such 
as changes in wettability, are often deleterious.  Chemical crosslinking provides a greater 
control and residual chemicals can be removed by diligent rinsing after the cross-linking. 
Chemical crosslinking methods usually involve the use a bifunctional chemical 
agent that reacts with two collagen molecules, at two different sites, to create a bond 
between them by becoming incorporated into the chemical linkage.  Ideally the bonds 
formed should be irreversible and stable.  The chemicals that have been used previously 
to create crosslinks are glutaraldehyde, formaldehyde, polyepoxy compounds, acyl azide, 
carbodiimides, hexamethylene diisocyanate and chromium tanning.[7,20]  Exceptions to 
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the bifunctional nature of most crosslinkers are carbodiimides, which only facilitate the 
formation of bonds without actually becoming part of the linkage.[7]  Only carbodiimides 
are discussed in detail here as this is the primary method employed for these studies.  For 
a complete review of collagen crosslinking see Friess[7] and Khor.[20]
2.1.2.1 Carbodiimides 
The principle advantage of using carbodiimides is the molecules are not required 
to be bifunctional and highly reactive to create the stabilizing bonds.[7]  This results in 
more predictable reactions and fewer unwanted, side reactions.  The most common 
chemical used in the class of carbodiimides to crosslink collagen is 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC).  EDC is widely used to 
conjugate proteins in many biotechnology processes.[21]  The molecule activates the 
carboxylic acid side groups of proteins, usually aspartic and glutamic acid residues in the 
case of collagen, which then react with the amine groups of other polypeptide chains to 
create amide bonds.[22]  The mechanism for this reaction is shown in Figure 1. 
Figure 1: EDC crosslinking mechanism 
Adapted from [23] 
 8
Crosslinking is performed in a mildly acidic environment to provide excess 
protons to initiate the reaction.  The specific pH of the reaction solution has been shown 
to effect the type of crosslinking that occurs.[24]  Optimization studies have found a pH of 
5.0-5.5 to be most effective.[24,25]  Due to the unstable amine reactive intermediate shown 
in Figure 1, the conditions of crosslinking have to be very carefully controlled to 
minimize unwanted side-products.  Specifically, the hydrolysis of the ester bond to 
produce the original carboxylic group on the protein and the subsequent alcohol 
substitution on the second imide bond, serve only to deactivate the crosslinker.  To 
prevent this, N-hydroxysuccinimide (NHS) is added to the 
reaction solution.[25,26]  The structure of NHS is shown in 
Figure 2.  This compound is more reactive than water and 
activates the ester bond before it is hydrolyzed.  The 
activated ester can then react with the amine group on an 
adjacent collagen molecule to create the crosslink. 
Figure 2: Structure of n-
hydroxysuccinimide 
Adapted from [27] 
Comparable crosslinking densities to 
glutaraldehyde, as measured by shrinkage or denaturation temperature, have been 
obtained using EDC.[28,25]  Increased compressive stiffness for cartilage implants[29] and 
reduced calcification[30] have also been demonstrated with EDC crosslinking compared to 
glutaraldehyde treatment.[29]  Furthermore, calcification of EDC treated implants is much 
less than glutaraldehyde implants post implantation.[28,30] 
EDC is limited by the number of amine groups available for reaction on the 
collagen molecule.[31]  The repeating tripeptide, Gly-X-Y (where X and Y are most 
frequently proline and hydroxyproline respectively), which makes up collagen, and the 
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tightly wound helical structure cause the number of available amine to be approximately 
30 groups per 1000 residues.[32]  The number of available carboxylic acid groups is 
greater, at approximately 120 groups per 1000 residues. 
A significant advantage of EDC crosslinking over other crosslinking methods is 
that it can be used in predictable manner to directly conjugate other proteins to the 
collagen matrix during the crosslinking treatment.  Frequently, researchers have 
attempted to direct cellular activity by incorporating specific ECM molecules into the 
matrix that cells will recognize.  The EDC molecule will react with proteins in solution 
and covalently bond them to available collagen molecules.  This strategy has been used to 
conjugate glycosaminoglycans (GAGs), which have been shown to influence fibroblast 
behavior, to the collagen matrix to improve biocompatibility.[33, 34]  The mechanism for 
this is shown in Figure 3.  This method could be used to attach a variety of molecules to 
the collagen matrix such that they are presented in a biological functional conformation, 
Figure 3: Conjugation of glycosaminoglycan to collagen using EDC 
Adapted from [26]
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provided they have a carboxylic group that can be modified without changing the 
bioactivity of the molecule. 
In this project, the ability to modify the scaffold to elicit different tissue responses 
will be utilized to create scaffolds with greatly varied yet predictable responses.  Large 
differences in the responses to the implant will increase the likelihood of discerning these 
tissue differences with MRI.  Previous studies examining the effects of different 
modifications to collagen matrices on the host responses are described below. 
2.1.3 Influence of Glycosaminoglycans 
Glycosaminoglycans are a class of ECM components that modulate cellular 
responses to scaffolds.  In physiological environments, glycosaminoglycans are present 
as side chains attached to 
larger proteoglycans.[34]  
The different hexuronic 
acids and hexosamine 
molecules link together in 
disaccharide repeating 
units with various 
sulfation patterns to create 
a wide variety of proteins 
that precisely direct 
various cell functions,[35] see Figure 4.  Cells attach to these proteins via integrins that 
initiate a signaling cascade within the cell that influence the cellular behavior. 
Figure 4: GAG function in ECM 
Adapted from Sasisekharan [35]
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Commonly studied glycosaminoglycans used in tissue engineering include 
heparin, heparan sulfate, dermatan sulfate, chondroitin sulfate, hyaluronan and hyaluronic 
acid.[36]  Increased fibroblast migration with the use of hyaluronate and chondroitin 
sulfate have been reported.[33]  Reduced foreign body reactions to collagen matrices with 
conjugated chondroitin sulfate and heparan sulfate have been demonstrated in 
subcutaneous implants.[37]  The use of collagen-GAG copolymers, which contain 
chondroitin sulfate, has also been studied extensively for use as skin regeneration 
templates.[13]
The ability to incorporate glycosaminoglycans into collagen scaffolds can be used 
to control the cellular behavior both in vitro and in vivo.  This approach will create 
significant differences in the tissue responses to the implants maximizing the likelihood 
of detecting these differences using MRI. 
2.2 Collagen Matrix Implantation 
Preliminary in vivo studies of various collagen matrices are most commonly 
performed using subcutaneous implantations, usually within dorsal compartments of rats.  
This is due to the ease of surgery for both placing and retrieving the implant.  
Subcutaneous implantations also facilitate MRI evaluation, as it allows for surface coils 
to be used instead of volume coils that generally have lower signal to noise ratios. 
Previous studies have extensively characterized tissue responses in this implant 
environment, making it a suitable choice for these studies.[38,39]  Tissue responses to 
implants are challenging to analyze quantitatively due to the complexity of living systems.  
Depending on the particular interest and aims of the researcher, different parameters may 
be measured.  These include the number and type of cells around and within the implant, 
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the activity of these cells in terms of protein synthesis and extracellular matrix (ECM) 
remodeling, as well as changes to the implant itself. 
2.2.1 Physiological Outcomes 
The numerous parameters that can be measured after the implantation of a 
medical device make the complete characterization of the tissue response challenging.  
Certain responses, such as the production of a discrete protein or cellular migration, may 
be more important to some types of implants.  The development of a noninvasive 
technique to monitor implants should be as general as possible to maximize its utility for 
various applications.  This thesis will concentrate on physiological outcomes that are 
fundamental to the success of all types of artificial tissue constructs.  Biocompatibility, 
degradation rates and angiogenic potential are all critical design criteria for implants that 
a noninvasive technique should be able to monitor.  These parameters have been 
extensively explored and consequently are well characterized in the literature. 
2.2.1.1 Biocompatibility 
The biocompatibility of an implant is a critical factor that must be addressed 
during the design and development.  The initial inflammation caused by the presence of 
the implant, a foreign material, and surgical implantation, is important to assess.  This 
response has a direct effect on the later tissue response as the wound healing cascade 
progresses.  The type and number of cells that are recruited to the implant environment, 
as part of the inflammatory response, have been previously studied to determine the 
biocompatibility of collagen implants.[40,41,42]
Polymorphonuclear cells (i.e. neutrophils) and monocytes/macrophages are the 
cells most commonly associated with foreign body induced inflammation.  Chemotactic 
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factors released during the inflammation recruit reparative cells, including fibroblasts, to 
the wound environment.[10]  A schematic of the evolution of cells surrounding the implant 
is shown in Figure 5.  These cells are usually identified and counted using a histological 
stain, such as hemotoxylin and eosin or toluidine blue, where the shape of the nucleus can 
be used to identify the cell. 
Figure 5: Evolution of cell type surrounding implant 
Adapted from [10]
Manual counting of individual cells in histological sections of tissue explants is 
prohibitively time consuming.  Semi-quantitative assessments have been previously 
reported by scoring randomly selected fields of view (FOV) for the number of cells 
within in the implant based on an arbitrarily defined scale.  These measurements are 
taken blinded by multiple researchers. 
2.2.1.2 Angiogenesis 
The ability to support angiogenesis has been identified as a critical factor for the 
success of tissue engineered scaffolds and consequently has received considerable 
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attention.[43]  Cells cannot survive further than a few hundred micrometers from the 
nearest capillary.  The regeneration of tissues larger than this requires vasculature to 
support viable cell populations within the scaffold.  Angiogenesis can be measured by 
quantifying the number of vessels within the implant using a variety of methods.  
Staining for markers specific to the microvasculature in explants allows capillaries to be 
identified.  Antibodies directed against the basal lamina marker collagen IV, platelet 
endothelial cell adhesion molecule-1 (CD31 or PECAM-1) and von Willebrand factor 
have all been used previously.[44]  Perfusion measurements using microangiography[45], 
computed tomography[46] and magnetic resonance micro-angiography[47] have been 
described to measure blood flow in vivo.  Alternatively MRI data that could correlate 
with the histological staining data, are in vivo measurements with gadolinium-based 
contrast agents such as gadopentate, gadoteridol and gadodiamide that are used to 
measure the perfusion of blood in a specific region of interest.[48]
2.2.1.3 Degradation 
Tissue scaffolds are designed as temporary constructs that are slowly degraded 
and replaced by native tissue.  The scaffold should persist long enough to facilitate new 
tissue ingrowth and wound healing, but should not persist and impede remodeling and 
neotissue regeneration.  The rate of biodegradation must be carefully controlled to 
achieve optimal wound healing.[13]
The degradation extent of collagen scaffolds can be measured using a variety of 
methods.  In vitro studies have previously used the change in dry mass[22], or 
spectroscopic methods, such as the hydroxyproline assay[49] to determine the 
concentration of solubilized collagen.  Mechanical properties have also been used to 
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determine the integrity of the scaffold.  Changes in tensile strength[22], compressive 
modulus[50] and stress relaxation[51] have all been previously reported. 
In vivo studies have described histomorphometry techniques to measure the extent 
of degradation.[52]  This is performed by measuring the area of each of the different 
regions on a slide, such as regions occupied by the implant material versus new tissue, 
blood vessels or empty space.  As the matrix degrades, the area it occupies in a randomly 
chosen FOV should decrease.  This analysis is usually carried out with the aid of a 
computer.  Excised collagen matrices have also undergone mechanical tests to assess the 
degradation.[53]  Alternatively, fluorescently-labeled antibodies targeted against the 
particular collagen species that the implant is made from can be used to quantify the 
amount of fluorescence and persistence of an implant.  However, histomorphometry 
provides quantitative data in an easier, more efficient manner than fluorescent imaging of 
tissue sections. 
2.2.2 Responses to Matrices 
The development of a noninvasive technique to monitor implants requires model 
implants with predictable and varied ranges of tissue responses for detecting a difference 
using MRI.  It will also allow a large range of data histological data to be correlated with 
the MRI measurements.  The different responses to collagen matrices are based on the 
different fabrication treatments they undergo prior to implantation.  This section will 
briefly review how the different treatments affect the biological response. 
Crosslinking has a significant effect on the tissue response to collagen matrices.  
Glutaraldehyde crosslinking has been shown to produce a greater initial inflammatory 
response compared to EDC crosslinking[28] and diisocyanate.[28,40]  However, cellular 
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infiltration of fibroblasts towards the center of the sponge at longer time periods was 
shown to be decreased as a result of glutaraldehyde crosslinking.  Cellular infiltration and 
inflammatory response is greatest in uncrosslinked sponges.[54]  Furthermore, increasing 
the glutaraldehyde crosslinking times were shown to decrease the initial inflammatory 
response.[54]  This is caused by the masking of antigens by crosslinks.[55]  EDC 
crosslinking produces samples with equivalent resistance to proteolytic attack, while 
improving the biocompatibility and amount of tissue ingrowth over glutaraldehyde 
treated samples.  The degradation rates for these crosslinking techniques were all found 
to be slower than uncrosslinked sponges. 
The incorporation of glycosaminoglycans (GAGs) and growth factors is another 
frequently used method to improve the tissue response.[41,42,37,13,56]  In a study performed 
by Pieper et al.[37] the addition of heparan sulfate and chondroitin sulfate was found to 
reduce the transient inflammatory response, increase infiltration by fibroblasts and 
increase the rate of new tissue deposition over uncrosslinked sponges and sponges 
crosslinked without GAGs.[37]  The results from this study are summarize in Table 1 . The 
presence of GAGs also decreased the degradation rate, preserving the porous structure 
compared to sponges with the same crosslinking density.  The sustained release of basic 
fibroblast growth factor has also been shown to increase new production and increased 
angiogenesis.[57]
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Table 1: Tissue response to glycosaminoglycans 
Cellular Events UnX EDC EDC+CS EDC+HS 
Inflammatory/immune 
cells 
++ +++ + ++ 
Fibroblasts/ECM 
deposition 
++ +++ +++ +++ 
Angiogenesis + + ++ +++ 
UnX = uncrosslinked, EDC = crosslinked using EDC carbodiimide, EDC+CS = EDC crosslinked with 
chondroitin sulfate, EDC+HS = EDC crosslinked with heparan sulfate.  Cellular events were scored as 
slight (+), moderate (++), and abundant (+++)  Table adapted from Pieper et al. [37]
2.3 MRI Overview 
Magnetic resonance imaging has emerged as a powerful tool in a variety of 
medical applications.  Its sensitivity to small changes in water environments and ability to 
probe tissues noninvasively has enabled it to become an extensively used technique.  The 
basic physical principles that give rise to a nuclear magnetic resonance (NMR) signal and 
how this is used to create an image are briefly explained here.  The basic types of images 
will also be discussed.  This section, adapted from Smith[58] and Haacke[59] describes the 
principles governing MRI to provide a basic, working knowledge of the technique as it 
applies to this project.  The reader is referred to other texts for a more thorough treatment 
of this material. 
2.3.1 Nuclear spin in a Magnetic Field 
Atoms with an uneven of number of neutrons or protons have a nucleus with a 
magnetic dipole arising from the unpaired spins of the nuclear particles.  A nucleus with a 
magnetic dipole can be considered analogous to a miniature bar magnet, with north and 
south poles, commonly represented as a vector.  These nuclei will interact with an 
external magnetic field, and are termed NMR active nuclei.  Commonly occurring NMR 
active isotopes include 1H, 14N, 23Na, and 31P.  The high abundance of 1H, simply a 
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proton, makes it a common atom to use for MR imaging, though it is possible to use other 
nuclei.[58]
When protons are placed within a large external magnetic field, the interaction 
between the external field and the nuclear magnetic fields causes the protons to align with 
the applied field.  When the protons are not aligned with the field (as during an 
experiment, when they have been excited), the interactions between the nuclear spin and 
the external magnetic field, lead to each proton precessing about the direction of the field.  
The angular frequency of this precession (ω0) is given by: 
(1) 00 Bγω =
Equation 1: Lamor equation 
where γ is the gyromagnetic ratio, a unique constant for each nuclei, and BB0 is the 
external magnetic field.  This precessional frequency is called the Lamor or resonance 
frequency.  For a proton, γ has a value of approximately 2.68 x 10  rad/s/Tesla.  The 
precessional frequency of a proton in a typical; magnetic field used in imaging is roughly 
within the frequency range used for radio waves. 
8
When a large number of protons are placed within a field, as occurs when a 
patient or specimen is inserted into the bore of a magnet, the protons align in the direction 
of the external magnetic field, by convention denoted as the z-direction.  Only two 
alignments are possible, parallel or anti-parallel to the magnetic field.  The parallel 
alignment has a slightly lower energy than the anti-parallel state, resulting in a greater 
number of nuclei in the lower energy state at equilibrium.  Most of the individual dipoles 
in one state will cancel with a proton dipole in the alternate energy state, but the slight 
excess of protons in the lower energy state will result in a very small net magnetization 
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aligned along the z-axis.  This quantity is called the spin excess and is used to generate 
the signal detected during NMR data collection. 
2.3.2 MRI Parameters and Their Physical Origins 
The basic NMR experiment to collect data involves perturbing a system subjected 
to a magnetic field from its equilibrium state by applying energy to the system.  As the 
system returns to equilibrium, the state of the system is measured as a function of time, 
by sampling at certain time points.  This is a broad simplification but serves illustrate the 
idea. 
At equilibrium, each proton has aligned with the magnetic field and the net 
magnetization (M0) is all in the z-direction represented by the symbol Mz (Mz = M0).  
There is no magnetization in the plane perpendicular to the magnetic field (Mxy = 0) at 
equilibrium, also called the transverse plane.  A radiofrequency (RF) coil is used to apply 
energy to the system and perturb it from equilibrium.  This is achieved by sending a 
current through the coil at a frequency that matches the precession frequency of the 
proton, hence creating resonance and achieving an efficient transfer of energy into the 
system.  By controlling the duration of the current, the net magnetization of the sample 
can by rotated a specified angle away from the direction of the field.  The hardware 
requirements for the coil, in order to match the frequencies and to achieve uniform 
excitation of the sample, are beyond the scope of this summary.  The system is then left 
to return to equilibrium.  During the restorative period, the same RF coil that was used to 
initially excite the system detects a current that is induced by the transverse 
magnetization as it returns to equilibrium. 
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The following sections will briefly describe the particular quantities that can be 
measured during an imaging session.  This will provide the reader with an introduction 
sufficient to understand the data that will be presented in this thesis. 
2.3.2.1 Longitudinal Relaxation 
The longitudinal relaxation time is a measure of the time it takes for the protons to 
return to equilibrium state after the system has been excited by a 90° pulse.  That is, a 
pulse which moves the net magnetization into the transverse plane such that Mz = 0 and 
Mxy = M0.  The interactions that cause the protons to relax back to their alignment in the 
z-direction are primarily due to environmental interactions and so longitudinal relaxation 
is often called spin-lattice relaxation.  As soon as the pulse is turned off, the transverse 
magnetization will begin to decay to zero and the longitudinal magnetization will recover 
to its equilibrium value.  Mathematically, the recovery of the magnetization in the z-
direction can be represented by 
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=
−
11)( 0
T
t
z eMtM (2) 
Equation 2: Longitudinal relaxation 
where time, t = 0 right as the pulse is turned off and T1 is the characteristic parameter that 
determines the rate of recovery of the longitudinal magnetization.  The T1 parameter can 
be thought of as the time it takes for the longitudinal magnetization to recover to 63% of 
its initial value. 
2.3.2.2 Transverse Relaxation 
In addition to the longitudinal relaxation, there is a faster relaxation process that 
occurs in the transverse plane.  This is sometimes referred to as in-plane dephasing.  
Initially, the protons are all aligned (phase coherent) immediately preceding the initial 
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pulse.  After this, the spins tend to “spread out” (diphase) due to variations in the local 
magnetic field caused by neighboring protons.  This leads to differences in the 
precessional frequencies that accumulate over time and tend to “fan out” the spins, thus 
reducing the net transverse magnetization which is the sum of all the individual 
transverse components (vectors of equal magnitude, but opposite directions will sum to 
zero).[59]  This is shown mathematically by Equation 3, where again, t = 0 as the pulse is 
turned off.  The T2 parameter can be thought of as the time it take for the transverse 
magnetization to decay to 37% of its original value, and is always less than or equal to 
the longitudinal relaxation. 
( ) ⎟⎠⎞⎜⎝⎛ −= 20 T
t
xy eMtM
(3) 
Characteristic plots of the longitudinal and transverse relaxation processes are 
shown in Figure 6, where the T1 time is 400ms, and Figure 7, where the T2 relaxation 
time is 100ms.  The magnitudes of Mz and Mxy have been normalized. 
Equation 3: Transverse relaxation 
Figure 6: Longitudinal relaxation curve 
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Figure 7: Transverse relaxation curve 
 
2.3.2.3 Image Acquisition 
Images require that the electrical signals from protons at different locations within 
the specimen can somehow be mapped back to their locations when the image is 
reconstructed.  Each pixel within a picture has its location defined by a set of coordinates, 
usually (x, y), that specify a location in perpendicular directions.  In order for the data, 
essentially induced currents within the RF coil, to be mapped back to the location within 
the specimen that they originated from, magnetic field gradients superimposed on the 
external magnetic field encode the spatial position of each volume element into the 
frequency and phase of the signal.  Additional coils within the magnet apply a gradient to 
the magnetic field that serve to alter the frequency that the protons precess, based on 
Equation 1.  Additional gradients are applied for a short time in the perpendicular 
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direction to alter the phase of all the protons.  The third spatial dimension is controlled 
during the excitation, where the system is perturbed from equilibrium only in the slice of 
interest.  This is accomplished by matching the frequency of the current in the RF coil 
with the spins in the slice of interest.  Thus, when the data is collected, it can be resolved 
back to unique (x,y) coordinates (within a specific slice) in an image based on the 
frequency and phase of the data.  The Fourier transformation is used to process the signal 
collected in the RF coil and to separate it into its individual components. 
2.3.2.4 Image Weighting 
The two relaxation processes, longitudinal and transverse relaxation, occur 
simultaneously.  When collecting data, it is impossible to halt one type of relaxation, and 
only measure the other.  Thus, when data is collected, there is always a mixture of signals 
from the two processes.  Based on when the samples are taken, and the original pulse 
sequences used to excite the sample, the data can be collected in such a way that the 
contrast of the image is dominated by a single relaxation process.  This is termed image 
weighting.  Additionally, it is possible to collect diffusion weighted images.  This will be 
discussed in Section 2.3.2.5. 
There are two basic timings of the pulses that can be manipulated to achieve the 
desired image weighting: 
• TR interval (time between excitation pulse repetitions) 
• TE interval (time at which the signal is measured after the pulse, echo 
time) 
A T1 weighted image is acquired using a short TR and short TE, which serve to enhance 
T1 contrast and minimize T2 contrast.  T2-weighted images are obtained using long TR 
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and long TE values, which have the opposite effect.  A third type of image-weighting can 
be obtained using long TR and short TE values, which reduces both T1 and T2 contrast 
and gives a proton-density-weighted image.  This is useful in determining how much 
water is in the specimen. 
2.3.2.5 Diffusion Measurements 
Collection of MRI data usually employs constant field gradients to spatially 
resolve the data and to select the various slices of interest.  Pulsed-field gradients may be 
used to encode the data with molecular diffusion information.  When molecules move 
from one region to another, they experience different magnetic field strengths that change 
their precessional frequencies.  These changes in resonant frequencies lead to 
accumulation of phase shifts (both positive and negative) that serves to attenuate the 
overall signal.  Stationary molecules will not experience the accumulation of phase shifts 
and exhibit no signal attenuation.  Using this data it is possible to create diffusion-
weighted images (DWI) that show where there is greater movement of water molecules 
based on a reduction of the signal. 
Pulsed-field gradients can only be used to detect diffusion in the direction of the 
pulsed-gradient field.  Multiple sets of data, with different directional orientations of the 
pulsed-field gradient, can be combined to obtain an overall description of diffusion in all 
directions.  This is performed to create a map of the apparent diffusion coefficient 
(ADC).  This gives the researcher an idea of how freely the water molecules are moving.  
While there may be diffusion of other larger molecules, such as proteins, these are 
generally too slow to be detected using pulsed-gradient fields. 
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2.3.2.6 Contrast Enhanced Imaging 
The mechanisms through which protons transfer energy to their surroundings and 
thereby relax can be manipulated to significantly alter the relaxation times.  The exact 
principles by which this occurs are beyond the scope of this summary.  Alterations to the 
relaxation times are achieved through the use of MRI contrast agents.  These substances, 
when introduced at low, non-toxic concentrations, interact with the water molecules to 
accelerate the relaxation processes.  The transfer of energy from the spins into the lattice 
is made more efficient.  Image contrast is thereby increased, allowing for better image 
analysis in certain cases by allowing different tissues to be more clearly distinguished.  
The change in relaxation times can also be used to monitor the progression of the contrast 
agent through the tissue.  For example, if the agent is introduced intravenously, the blood 
vessels will experience the change in relaxation times first.  As it diffuses out the blood 
vessels into the surrounding cells, tissues with a greater vessel density will show on the 
image before tissues with a lesser blood supply.  The clearance of the contrast agent can 
also be used in a similar manner to characterize the tissues. 
2.3.3 MRI Implant Evaluation 
Previous studies have used MRI to investigate the changes in various biomaterials 
after implantation.  Constantinidis et al.[60] used MRI methodologies to monitor cellular 
distribution and metabolism of adult porcine islet cells and βTC3 cells encapsulated 
within alginate/poly-L-lysine/alginate beads both in vitro and in vivo.  They showed that 
diffusion-weighted imaging is most useful for locating the spheres within mice and that 
the metabolism of the cells can be monitored using NMR spectroscopy. 
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It has also been shown that changes in T2 relaxation times are sensitive to changes 
in the histological state of the poly[N-(2-hydroxypropyl) methacrylamide] (PHPMA) (a 
hydrogel) implants.  In this study, Traoré et al.[61] found that the T2 relaxation data could 
be fitted using a biexponential model after a certain amount of time within the animal, 
indicating heterogeneity within the implant.  This could be attributed to cellular 
infiltration creating distinct volumes within the implant, that could be distinguished using 
MRI, where slow and fast T2 relaxation times were associated with volumes containing 
few cells or many cells, respectively.  Other studies using NMR imaging and 
spectroscopy, as well as cell labeling, have characterized implants and tissue 
responses.[62,63,64]  Choi et al.[64] have used gadolinium-enhanced magnetic resonance 
imaging to study the fibrovascular ingrowth into polyethylene orbital implants.  They 
found that the area of fibrovascular tissue, as measured by histology and MRI, correlated 
very well. 
MRI is also extensively used in the clinical setting to evaluate the pathology of 
soft tissues.  T2-weighted imaging has been used in stroke[65] and tumors of various 
organs such as the heart,[66] pancreas,[67] and liver[68].  T1-weighted imaging is generally 
most useful to obtain information about the general anatomy as it provides good 
structural images of the various organs.  Diffusion-weighted imaging is often used in 
assessing multiple sclerosis[69] and in the imaging to tumors.[70-72]  The relationship 
between cellular density and MRI measurements of T2 and ADC has been studied 
extensively in tumors.[70,73,74]  These studies have demonstrated that cellularity can be 
monitored using these parameters.  Contrast-enhanced imaging is also used extensively to 
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assess the vasculature of certain regions and to measure the angiogenesis of tumors.[75]  
This same approach can be used to measure the angiogenesis within the scaffolds. 
These studies, and many others, have examined the affects that physiological 
changes, which occur in disease states, have on the MRI measurements.  They 
demonstrate significant progress towards understanding how to collect and interpret the 
MRI data to obtain useful information that can guide clinical diagnoses and treatments.  
This body of work describes one of the first studies that applies these techniques to 
assessing tissue responses to implanted collagen scaffolds.  An MRI assessment of 
collagen scaffolds was closely correlated with histological findings to demonstrate that 
MRI can be used to monitor these implants using techniques similar to those in common 
use. 
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3 Hypothesis and Specific Aims 
We hypothesized that changes in tissue responses to implanted collagen scaffolds 
will correlate with changes in the MR images.  Specifically, quantitative analyses of 
cellular infiltration, tissue ingrowth, and vascularization of scaffolds will correlate with 
MRI measurements of T2 relaxation times, water apparent diffusion coefficients, and 
contrast agent uptake/clearance profiles within the implant.  The following correlations 
were tested: 
• Average T2 values and average cellular density 
• Average T2 values and average void area 
• Average ADC values and average cellular density 
• Average ADC values and average void area 
 
Specific Aim 1: Characterize in vitro scaffold degradation. 
Scaffolds were fabricated and modified to produce three different groups; 
uncrosslinked, crosslinked, and crosslinked in the presence of chondroitin sulphate to 
conjugate this glycosaminoglycan to collagen.  To measure the degradation rates, these 
scaffolds were treated with bacterial collagenase and the collagen degradation products 
were analyzed using a hydroxyproline assay. 
Specific Aim 2: Quantify cellular infiltration into the scaffold. 
Scaffolds were implanted into dorsal subcutaneous pockets of rats, harvested at 2, 
7, 14, 21, 28, 35 and 42 days, and histological sections were stained using Haematoxylin 
and Eosin as well as Masson’s Trichrome.  Cellular density as a function of depth within 
the scaffold was measured using automated image analysis software. 
 
 
 29
Specific Aim 3: Quantify vascularization of the scaffold. 
Using histological sections obtained from the explants described above, blood 
vessels within the scaffold were characterized using Masson’s Trichrome stained sections 
to determine the vessel density as a function of depth within the scaffold. 
Specific Aim 4: Quantify new tissue deposition within the scaffold. 
Using histological sections obtained from the explants described above, the void 
area remaining within the scaffolds were measured using Masson’s Trichrome stained 
sections, again as a function of depth within the scaffold. 
Specific Aim 5: Correlate histology and MRI data. 
MRI parameters were correlated with histological measurements of the same 
scaffold to determine whether correlations were statistically significant and to formulate 
specific algorithms or criteria that facilitate the interpretation of MRI measurements. 
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4 Materials and Methods 
This section contains a description of the procedures used to accomplish the body 
of work in this thesis.  All chemicals were obtained from Sigma Chemical Co, St. Louis, 
MO, unless otherwise specified.  Details of the MR imaging were summarized from 
Kandasamy.[76]
4.1 Scaffold Fabrication 
Collagen scaffolds were fabricated from fibrillar collagen extracted from bovine 
Achilles tendon (Sigma, St. Louis, MI).  A 1.6% (w/v) dispersion of collagen was 
prepared in 0.5M acetic acid and left overnight at 4°C.  The dispersion volume was 
doubled with cold distilled water (final collagen concentration 0.8 wt%) and blended in a 
water-cooled homogenizer for 30min at 4°C.  The dispersion was then degassed under 
vacuum and stored at 4°C.  Forty milliliters of the dispersion was placed in an aluminum 
weighing pan (70mm diameter) and frozen at -80°C.  Once completely frozen, the pan 
was placed in a freeze dryer (Virtis Advantage, Virtis, Inc., Gardner, NY), initially set at 
-45°C, and lyophilized overnight.  Punches of the lyophilized collagen sheet were made 
to produce disks of diameter 1.5 cm and thickness one cm, weighing approximately 
20mg.  Scaffolds were stored in a sealed desiccator at room temperature until used. 
Scaffolds were crosslinked using 1-ethyl-3-(3-dimethyl aminopropyl) 
carbodiimide (EDC) in the presence and absence of shark cartilage chondroitin 6-
sulphate (CS), according to previously described protocols,[37,26] to create differential 
tissue responses that would be detected by both MRI and histological analyses. Scaffolds 
were initially hydrated under vacuum in 50mM of 2-morpholinoethane sulphonic acid 
(MES) prepared in 40% (v/v) ethanol and adjusted using 1N NaOH/HCl to pH = 5.0 
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(referred to as MES buffer).  A crosslinking solution containing 0.4294g EDC and 
0.1473g n-hydroxysuccinimide (NHS) per gram of collagen scaffold to be crosslinked.  
Solution volumes and reagent masses were varied depending on how many samples were 
prepared.  To conjugate CS to the scaffolds during the crosslinking process, CS was 
added to the crosslinking solution to make a 1.2% solution (w/v, chondroitin sulphate to 
crosslinking solution).  Scaffolds were then incubated in the crosslinking solution and 
crosslinking was allowed to proceed for four hours at room temperature.  Scaffolds were 
then rinsed with 70% (v/v) ethanol (4 x 30 minutes) and sterile phosphate buffered saline 
(5 x 15 minutes).  The scaffolds were left in the final PBS rinse and stored at 4°C for no 
more than two days.  Three types of scaffolds were fabricated: uncrosslinked (UnX), 
crosslinked (EDC) and crosslinked in the presence of CS (EDC+CS). 
4.2 In Vitro Degradation of Scaffolds 
Scaffold degradation was investigated using previously described methods for 
enzyme treatment by Pieper et al.[26] and hydroxyproline measurement.[49] Scaffolds were 
rinsed in 0.1M Tris-HCl buffer containing 0.05M CaCl2 (pH 7.4).  A proteolytic solution 
was prepared by dissolving bacterial collagenase (Clostridium histolyticum, Calbiochem, 
San Diego, CA), at a concentration of 200 collagen digestion units (CDU) per ml, in the 
same Tris-HCl buffer.  All solutions were maintained at 37°C during the degradation and 
scaffolds were agitated on a gyratory mixer.  Samples (1ml) were taken daily, after 
centrifuging tubes at 2,000 rpm (Allegra 6R, Beckman-Coulter, Fullerton, CA) for five 
minutes, and replaced with fresh collagenase solution.  Each sample was stored frozen at 
-20°C until analyzed for hydroxyproline content.  Photographs were taken using a digital 
camera (Nikon D50, Nikon Corporation) at each sample time. 
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Hydroxyproline concentrations in the supernatant samples from degraded 
scaffolds were assessed according to the method of Woessner.[49]  A buffer (H-Pro buffer) 
was prepared by combining 12 ml glacial acetic acid, 50 g citric acid monohydrate, 120 g 
sodium acetate trihydrate, 34 g NaOH and bringing to a final volume of one liter (pH 
6.0).  Half-milliliter portions of the supernatant samples, and standard solutions of known 
collagen concentrations, were combined with a half-milliliter of 12 N HCl in glass test 
tubes sealed tightly with Teflon-lined screw caps (Fisher Scientific, Springfield, NJ).  
The samples were then hydrolyzed at 110°C for 18 hours in an oven.  Tubes were then 
cooled and the hydrolyzates were neutralized with 6 N NaOH containing Phenol Red.  
Fine adjustments were made to ensure the pH was between 6.0 and 7.0, corresponding to 
an orange/yellow color of the indicator.  Each hydrolyzate was brought to a total volume 
of seven ml using distilled water.  Portions of hydrolyzate (75 μl each) were placed in 
individual wells of a 96-well plate.  Then, 37.5 μl of 0.05 M of chloramine-T (sodium p-
toluenesulfonchloramide), prepared in H-Pro buffer, water, and methyl cellosolve, mixed 
in a ratio of 5:2:3, respectively, was added to each well and allowed to react for 20 
minutes at room temperature.  In the same order that chloramine-T was added, 37.5 μl of 
3.15M perchloric acid was added to each well and allowed to react for five minutes at 
room temperature.  In the same order again, 37.5 μl of 1.34 M Ehrlich’s reagent solution 
(p-dimethylaminobenzaldehyde dissolved in methyl cellosolve) was added to each well 
and mixed.  After the addition of Ehrlich’s reagent, the well plate was heated to 60°C in a 
water bath for 20 minutes.  The plate was then cooled in running tap water for five 
minutes and the absorbance of each well was read immediately at 561 nm using a 
SpectraMax 250 spectrophotometer (Molecular Devices, Sunnyvale, CA).  
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Concentrations were determined by comparing absorbance values against a linear 
standard curve.  When the data were plotted the values were adjusted to account for the 
dilution due to multiple samples.  Two scaffolds of each type were degraded, and thirteen 
supernatant samples were taken from the collagenase solution of each scaffold during the 
degradation. 
4.3 In Vivo Scaffold Assessment Using MRI 
All animals were handled and cared for in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals[77] and all experimental protocols were carried out 
with the approval of the University of Massachusetts (UMASS) Medical School 
Institutional Animal Care and Use Committee (IACUC Protocol A-1759).  No surgeries 
were performed at Worcester Polytechnic Institute. 
Male Sprague-Dawley rats (six to seven weeks 
old, seven rats total) were anesthetized using 
pentobarbital and xylazine dosed at 40 mg/kg and 10 
mg/kg respectively.  A dorsal midline incision, 
approximately six cm long was made from the middle 
of the thoracic vertebrae towards the tail using a 
scalpel.  Six subcutaneous pockets (three per side 
lateral to the incision) were made using blunt 
dissection.  A hydrated, sterile-rinsed scaffold was 
placed in each pocket.  The type of scaffold placed at 
each location is shown in Figure 8.  Scaffolds were 
secured to prevent movement by passing 4-0 
EDC 
UnX 
EDC+CS 
Figure 8: Scaffold implant locations 
Adapted from NIH[78] 
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monofilament nylon (Ethicon, Summerville, NJ) through the scaffold and skin and tying 
two knots on opposite sides of the scaffold.  Animals were returned to their cages to 
recover from the anesthesia.  Once the animals were ambulant, they were returned to the 
animal housing facility. 
The rats were imaged two days after surgery, and every week after surgery up to 
six weeks.  For imaging, rats were anesthetized by placing them in a closed plastic 
container and administering 1.5% isoflurane delivered in 1.5 l/min of breathing quality 
air until the rat was fully sedated.  The level of isoflurane was reduced and adjusted as 
necessary during the course of imaging to maintain sedation.  The animal was placed in a 
custom-built animal holder to control its position within the bore of the magnet and its 
body temperature was maintained by circulating warm air. 
MR imaging was performed using a Bruker Biospin 2.0T/45cm imaging 
spectrometer and respiratory gating hardware and a custom-built surface coil that allowed 
all scaffolds to be imaged simultaneously.  T2-weighted images were acquired using a 
multiple spin echo pulse sequence (TR=2500 ms, TE = 12, 24, 36, 48, 60, 72, 84, 96, 
108, 120, 132, 144 ms, Nex = 2).  Images were oriented sagittally and each imaging slice 
was two mm thick. 
Contrast-enhanced T1-weighted MRI was performed using a spin-echo pulse 
sequence (TR/TE = 600/10 ms, Nex = 2).  A pre-contrast image was acquired, and then 
MAGNEVIST® (Gadolinium-DTPA, Bayer HealthCare) was administered at 
manufacturer’s recommended dosage of 0.1 mmol/kg via a tail-vein injection.  Post-
injection images were then acquired at regular intervals to monitor the uptake and 
clearance of the contrast agent. 
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Diffusion-weighted images were collected using a spin-echo, echo-planar imaging 
pulse sequence with diffusion sensitization applied along the read gradient at six b-values 
(b = 15, 60, 140, 390, 560, 760 mm2s-1).  Other acquisition parameters were TR/TE = 
2000/53, diffusion gradient duration δ = 4.0 ms, diffusion gradient separation Δ = 35 ms.  
These data sets were used to created apparent diffusion coefficient (ADC) maps. 
Rats were euthanized by intracardiac delivery of euthanasia solution 
(pentobarbital, 200mg/kg) at days 2, 7, 14, 21, 28, 35, 42.  Scaffolds were harvested by 
cutting the suture that secured it to the skin, taking care to preserve the capsule and 
surrounding tissue, and excising the scaffold with sufficient peripheral tissue to allow for 
viewing of normal, unaffected tissue in sections.  All scaffolds were then processed for 
histological analysis.  One rat was euthanized at each time point, for a total of 42 scaffold 
samples. 
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4.4 Histological Analysis 
Scaffolds were placed in tissue cassettes (Fisher Scientific, NJ) and fixed in 10% 
buffered formalin.  After rinsing in tap water, scaffolds were cut along the diameter of the 
scaffolds as shown in Figure 9.  At earlier time points, where the scaffold is much larger, 
a second cut, perpendicular to the first was sometimes necessary to divide the scaffold 
into quarters.  Photographs show gross morphological appearance of scaffolds at time at 
removal in Figure 10. 
A B A B
Embedded sponges 
Harvested scaffold 
Figure 9: Scaffold processing 
A) B)
Figure 10: Harvested scaffolds 
A) EDC scaffold harvested at 2 days.  B) Scaffold cut parallel to midline to facilitate embedding and 
sectioning. 
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After fixing and trimming, samples were dehydrated through a series of ethanol 
baths with gradually increasing ethanol concentrations.  Samples were cleared in 2-
butanol and embedded in paraffin wax at 60°C such that all the sections were cut in the 
same plane as the original midline incision made during the implantation surgery.  This is 
the same orientation used to acquire the MR images and allows for easier comparison 
between MR images and histological sections.  Sections were cut at 5 μm on a rotary 
microtome (American Optical) and placed on poly-l-lysine coated slides (Erie Scientific 
Company, Portsmouth, NH).  Sections were stained with modified Harris Hematoxylin 
and Eosin (Richard-Allen Scientific, Kalamazoo, MI) and Masson’s Trichrome (Sigma, 
St. Louis, MI) using standard procedures.  Slides were mounted with Permount® (Fisher 
Scientific, NJ) and imaged using a 10x objective on a Nikon E400 microscope, coupled 
with an RT Color Spot camera (Diagnostic Instruments, Inc Sterling Heights, MI).  Image 
capture was performed using Spot Analysis 4.0.9 software (Diagnostic Instruments).  A 
series of overlapping images were taken across the thickness of the scaffold, from the 
dorsal to ventral surfaces of the scaffold, including the surrounding fibrous capsule and 
tissue.  Images were then merged into a large, single mosaic using ImageJ (NIH, 
Bethesda, MD[79]) and the MosaicJ (Swiss Federal Institute of Technology, Lausanne, 
Switzerland[80]) plug-in. 
4.4.1 Thickness 
Total thickness of the implant, including the surrounding fibrous capsule, was 
measured using reconstructed mosaics of the H&E stained sections.  Dense, aligned 
connective tissue was used to identify the capsule.[81]  The change from dense connective 
tissue to looser, normal fascia was used to identify the margin between the capsule and 
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the surrounding tissue.  Within the capsule, the fibrous ribbons of the collagen scaffold 
were used to identify where the scaffold and capsule met.  From these sections scaffold 
thickness and capsule thickness were measured. 
4.4.2 Cellular Density 
Cellular density was measured 
using H&E mosaic images.  The 
contrast between cell nuclei stained 
blue/black and other structures 
stained pink/red allowed for easy 
identification of the nuclei.  Each 
mosaic was divided into 10 equally 
sized regions (see Figure 11) that 
spanned the entire thickness of the 
scaffold and included the capsule, but 
not the surrounding tissue.  As the 
implant changed size with 
implantation time, the size of each 
region changed, effectively 
normalizing to the thickness of the 
scaffold.  This ensured that an equal number of measurements were taken from each 
sample and allowed for comparisons between differently sized samples based on relative 
location within the scaffold.  The number of cell nuclei within each region was counted 
using semi-automated image analysis.  A macro was written for ImageJ to facilitate 
Figure 11: Region selection of an H&E stained cross-
section of an explanted scaffold 
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repeatable, consistent measurements in a time effective manner.  A schematic of the 
approach used in shown in Figure 12.  Each image was split into hue, brightness and 
saturation stacks.  The brightness stack provided the best contrast between nuclei and 
surrounding tissue based on the darker staining of the nuclei.  ImageJ commands were 
then used to subtract background image noise and automatically adjust the contrast and 
brightness.  The resulting image was then converted to a binary image by using the same 
threshold values for all images to isolate the dark regions (nuclei) of the image.  The 
same threshold values were used in all cases.  The “analyze particles” command was then 
used to automatically count the number of nuclei in the image.  For complete details, 
please see the appendix which shows the code used. 
A) B) D)C) 
Figure 12: Semi-automated image analysis of H&E stained region to count cells 
A ROI of an H&E stained section (A), was split into hue, saturation and brightness stacks.  The brightness 
stack (B) was thresholded (C) and analyze particles were used to count cells (D). 
4.4.3 Blood Vessel Density 
The number of blood vessels present in 
each sample was determined using regions 
taken from Masson’s Trichrome-stained 
sections, using the method described in Section 
4.4.2 to divide the scaffold into 10 equally sized 
regions (Figure 11).  Blood vessels were 
identified as circular structures larger than 8 μm 
Figure 13: Masson's Trichrome section 
used to count blood vessels 
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Arrows show blood vessels. 
in diameter surrounded by cells enclosing an empty space or only showing red blood cells 
within the structure, Figure 13.  Occasionally, vessels were sectioned longitudinally; 
these were counted as one unless branches were visible.  In this case, each branch was 
counted as one vessel. 
4.4.4 Void Area 
Masson’s Trichrome staining was also used to measure the void, or blank, area of 
the scaffold.  This gives a measurement of the overall density of the scaffold that can be 
correlated with MRI measurements of ADC and T2.  The same method was used to divide 
the scaffold into 10 equally sized regions as shown in Figure 11. 
The void area of each region was measured and reported as a percentage of the 
total area.  A macro was written for ImageJ to ensure consistent, repeatable results in a 
time effective manner.  A schematic of the approach used in shown in Figure 14.  Again, 
the images were split into hue, saturation and brightness stacks.  The brightness stack was 
selected and the background image noise subtracted.  The image was then converted to a 
binary image using threshold values that isolated the light regions from the remainder of 
the image.  The percent of pixels that fell into the light category was measured.  For 
complete details please see appendix for the code used. 
A) B) D)C) 
Figure 14: Semi-automated image analysis of MT stained region to measure void area 
A ROI of an Masson’s Trichrome (MT) stained section (A), was split into hue, saturation and brightness stacks.  The 
brightness stack (B) was thresholded (C) and number of pixels thresholded were counted (D). 
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4.5 Correlation of MRI and Histology Data 
MR images were acquired and analyzed by Kandasamy.[76]  As part of the MRI 
analysis, scaffolds were divided into center and rim regions, as shown in Figure 15.  
These regions varied by implant and day on which the imaging was performed.  
Generally, the rim region consituted the outer fifth of the scaffold.  To correlate these 
measurements with histology parameters, edge and core regions were defined as the outer 
20% and middle 20% of the scaffold, respectively. 
Figure 15: MR ROI selection 
Contrast enhanced images of scaffold from Kandasamy,[76] showing how MRI 
ROIs were selected. 
 
Correlations between the MRI data and histology data were performed by 
comparing MRI measurements taken immediately before the rat was euthanized with the 
histological measurements for each scaffold.  Average scaffold values from MRI 
measurements of T2, apparent diffusion coefficient (ADC) and volume for scaffolds were 
plotted against histology measurements of average cell density, void fractions and 
scaffold thickness.  T2, ADC, cell density and void fractions were averaged for the whole 
scaffold.  Comparisons were made only in cases where histology and MRI data points 
were available for the same scaffold, reducing the total number of data points available. 
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5 Results 
5.1 In Vitro Scaffold Degradation 
Scaffolds were incubated in a proteolytic solution of bacterial collagenases to 
assess the effect the crosslinking treatment on the degradation of the scaffolds.  The 
progression of scaffold degradation is shown in Figure 16.  UnX scaffolds showed the 
first signs of degradation at 72 hours; by 96 hours they were noticeably fragmented 
(Figure 16D).  The UnX scaffolds had reduced to fragments by 264 hours.  In contrast, 
Figure 16: Scaffold degradation photographs showing scaffold degradation 
A), D), G) and J) show UnX scaffolds at 0, 96, 240, and 312 hours respectively.  B), E), H) and K) show 
EDC scaffolds at 0, 96, 240 and 312 hours respectively.  C), F), I) and L) show EDC+CS scaffolds at 0, 96, 
240 and 312 hours respectively.  For size reference, all scaffolds were photographed in 50ml conical tubes 
(approximately 30mm in diameter). 
A) 
D) 
G) 
J) 
B) C)
E) F)
H) I) 
K) L)
0 
hrs 
96 
hrs 
240
hrs 
312
hrs 
UnX EDC EDC+CS 
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the crosslinked scaffolds maintained their integrity until 240 hours (Figure 16H and I), 
and thereafter showed only slow and faint signs of structural collapse.  By 312, hours the 
crosslinked sponges had completely fragmented, Figure 16K.  Based on observations, it 
appeared that the EDC crosslinked scaffolds were slightly more resistant to degradation 
than the EDC+CS scaffolds and released fewer fragments into the solution at any given 
time point. 
Supernatant samples were taken every 24 hours, while the scaffolds were 
degrading, and analyzed for hydroxyproline content.  The results shown in Figure 17 
indicate that the UnX scaffolds degraded quicker than the crosslinked ones.  At all time 
points the UnX scaffolds had released more collagen into the solution.  The 
Figure 17: Plot of solubilized collagen released during degradation assay 
Collagen scaffolds were exposed to bacterial collagenase and measures of hydroxyproline were correlated to 
solubilized collagen, results from one experiment, n = 2. 
 44
hydroxyproline measurements do not show any difference between the EDC- and 
EDC+CS-crosslinked scaffolds.  The slight increased resistance to degradation of the 
EDC scaffolds based on observations of the structure and fragments, was not confirmed 
by the spectrophotometric measurement.  Care should be taken interpreting these results 
due to the small sample size. 
5.2 Histological Analysis 
Scaffolds were implanted into dorsal subcutaneous pockets of rats to evaluate 
tissue responses.  Rats were imaged using MRI and the scaffolds were harvested to assess 
cellular responses.  Scaffolds harvested at Day 21 were infected and not processed for 
further analysis.  Explants were stained with H&E and Masson’s Trichrome and mosaic 
images of the thickness were created.  The mosaic images, Figure 18,Figure 19 andFigure 
20, show H&E sections of UnX, EDC and EDC+CS scaffolds, respectively.  Masson’s 
Trichrome mosaic images, Figure 21,Figure 22 andFigure 23 show UnX, EDC and 
EDC+CS scaffolds, respectively.  All scaffolds showed an increase in cell number from 
the scaffold margin that gradually filled the entire thickness of the scaffold for all 
scaffolds by Day 14.  UnX scaffolds had a greater number of inflammatory cells than 
crosslinked scaffolds.  After 14 days, the majority of cells within the crosslinked 
scaffolds were non-inflammatory.  After 14 days the UnX scaffolds had degraded 
completely (Figure 18) while the crosslinked scaffolds persisted to the last time point, 42 
days (Figure 19F, and Figure 20F).  Scaffold thicknesses decreased with time after day 
14, for both crosslinking conditions, except for Day 42, where the scaffolds were thicker 
than those harvested at Day 35 (Figure 24). 
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Generally, UnX scaffolds had thicker capsules than crosslinked scaffolds at all 
time points.  At Day 2 there was very little evidence of a capsule (Figure 21A, Figure 
22A and Figure 23A).  Capsule thickness increased up to Day 14, and then decreased as 
scaffold became integrated with the tissue. At Day 28, there was only a thin capsule 
surrounding the EDC scaffolds (Figure 22D).  After this time point, the scaffolds had 
completely integrated with the surrounding tissue.  EDC+CS scaffolds showed no 
capsule at Day 28 (Figure 23D), indicating quicker integration with the surrounding 
tissue. 
The porous structure of the scaffolds was gradually filled with cells, connective 
tissue and blood vessels.  UnX scaffolds appeared to degrade faster than new tissue grew 
in.  In contrast, crosslinked scaffolds maintained their structure while the pores were 
filled by actively remodeling fibroblasts.  The pores of EDC and EDC+CS scaffolds were 
completely filled by new tissue deposition by 28 and 35 days respectively, as seen by the 
increased staining of blue structures in Figure 23 E) and Figure 23D), indicative of new 
connective tissue synthesis. 
The following sections provide quantitative analyses of changes in tissue 
responses that were measured as a function of scaffold crosslinking and implantation 
time. 
 A) B) C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Mosaic photomicrographs of H&E sections of UnX scaffolds 
Images show scaffolds at A) 2 days, B) 7 days and C) 14 days oriented with dorsal side up.  Dotted line denotes margin between scaffold and surrounding tissue.  
Scale bar = 500 μm. 
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Figure 19: Mosaic photomicrographs of H&E sections of EDC scaffolds 
Images show scaffolds at A) 2 days, B) 7 days, C) 14 days, D) 28 days, E) 35 days and F) 42 days oriented with dorsal side up.  Dotted line denotes margin 
between scaffold and surrounding tissue.  Scale bar  = 500 μm. 
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Figure 20: Mosaic photomicrographs of H&E sections of EDC+CS scaffolds 
Images show scaffolds at A) 2 days, B) 7 days, C) 14 days, D) 28 days, E) 35 days and F) 42 days oriented with dorsal side up.  Dotted line denotes margin 
between scaffold and surrounding tissue.  Scale bar  = 500 μm. 
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A) C) B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Mosaic photomicrographs of Masson's Trichrome sections of UnX scaffolds 
Images show scaffolds at A) 2 days, B) 7 days and C) 14 days oriented with dorsal side up.  Dotted line denotes margin between scaffold and surrounding 
tissue.  Scale bar  = 500 μm. 
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Figure 22: Mosaic photomicrographs of Masson's Trichrome sections of EDC scaffolds 
Images show scaffolds at A) 2 days, B) 7 days, C) 14 days, D) 28 days, E) 35 days and F) 42 days oriented with dorsal side up.  Dotted line denotes margin 
between scaffold and surrounding tissue.  Scale bar  = 500 μm. 
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A) B) C) D) E) F) 
Figure 23: Mosaic photomicrographs of Masson's Trichrome sections of EDC+CS scaffolds 
Images show scaffolds at A) 2 days, B) 7 days, C) 14 days, D) 28 days, E) 35 days and F) 42 days oriented with dorsal side up.  Dotted line denotes margin 
between scaffold and surrounding tissue.  Scale bar  = 500 μm.
 
 
 
5.2.1 Thickness 
Scaffold thicknesses were measured using the mosaic images to quantify the 
change in size of the scaffolds to correlate with the MRI measurements of scaffold 
volume.  The results are shown in Figure 24.  These measures show an increase in 
crosslinked scaffold volume at Days 7 and 14, that is more marked for EDC+CS 
scaffolds than EDC.  After Day 14, the scaffold thicknesses decrease with implantation 
time, except for Day 42 where there is a slight increase.  UnX scaffolds show greater 
capsule thicknesses than crosslinked scaffolds at Day 7 and 14, but not Day 2.   By Day 
28, there is only a very thin capsule present around the EDC scaffolds, approximately 50 
μm, while the EDC+CS scaffolds show no evidence of a capsule after Day 14. 
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Figure 24: Scaffold thickness as a function of implantation time 
n = 2 for all bars. 
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5.2.2 Cellular Density 
Cellular infiltration into the 
scaffolds was measured by counting 
the number of cells within regions 
taken across the thickness of the 
scaffold to determine the cellular 
density at various depths within the 
scaffold.  Region size was 
normalized to the total thickness of 
the scaffold to ensure an equal 
number of measurements were 
taken from each scaffold, despite 
greatly varying sizes.  The results 
obtained for cellular density for the 
three types of scaffolds are shown in 
Figure 25. 
These plots show a general 
increasing trend in cell numbers 
with increasing time for all 
scaffolds.  Cellular density is 
initially high at the scaffold margins 
and increases in the core regions of 
the scaffold with longer Figure 25: Plots of cellular densities for UnX, EDC and 
EDC+CS scaffolds as a function of scaffold location and 
implantation time 
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implantation times.  Cell density at the margins of UnX scaffolds is higher than 
crosslinked sponges at 2, 7 and 14 days.  This is consistent with qualitative observations 
from Figure 18.  UnX scaffolds also show a faster increase in cellular density in the core 
regions compared to crosslinked scaffolds at Day 14. 
EDC scaffolds had cellular densities that were lower than UnX, but slightly 
higher than EDC+CS scaffolds, particularly at Day 2.  This trend continued until Day 35, 
where the EDC+CS showed a relatively homogenous distribution of cells, whereas the 
EDC scaffolds still had a markedly reduced density at the core regions on Day 35.  By 
Day 42, the cellular densities of the two crosslinked scaffolds were similar, with the 
EDC+CS scaffolds having fewer cells on the ventral side of the scaffold.  Besides this 
one case, the cellular infiltration appears to occur at a similar rate from both directions 
into the scaffold, resulting in a mostly symmetrical distribution of cells at any given time 
point. 
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Figure 26: Core and edge cell density 
Each point is an average of outer and middle 20% of scaffold (4 measurements per data point, n = 2) 
The cellular densities of the edge and core regions (20% of total scaffold 
thickness for each region were compared for various scaffolds), and the results are shown 
in Figure 26.  This figure shows more clearly the increased cell density at the scaffold 
edges, compared to the core regions.  The steady increasing trend of cells at the core of 
the scaffold is also observed, with core regions exceeding the cell density of the edge by 
Days 14 and 42 for UnX and EDC+CS scaffolds respectively.  EDC scaffolds show equal 
cell densities at Day 42.  Cellular densities at the edge of the crosslinked scaffolds 
decreases between day 7 and 14.  Again, UnX scaffolds show higher cell numbers than 
both crosslinked scaffolds and EDC scaffolds had marginally higher cell densities than 
EDC+CS scaffolds.  By Day 35, there is very little difference in cell density between the 
edge and core regions of the scaffolds. 
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5.2.3 Blood Vessel Density 
Angiogenesis within the 
scaffolds was measured by counting 
the number of blood vessels within 
regions, across the thicknesses of the 
scaffolds using the Masson’s 
Trichrome mosaics.  The results 
obtained are shown in Figure 27. 
No blood vessels were seen at 
Day 2 in any of the scaffolds.  At 
Day 7, UnX showed the greatest 
vascularity, which reduced by Day 14 
at the margins.  No blood vessels 
were seen in the center of the UnX 
scaffolds at any time point. 
Crosslinked scaffolds showed 
an increase in blood vessels with 
implantation time.  At Day 28, there 
were more blood vessels in the 
EDC+CS scaffolds than in the EDC.  
By Day 28, there were still regions of 
the EDC scaffold that did not contain 
any blood vessels.  However, at Day 
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Figure 27: Blood vessel densities for UnX, EDC and 
EDC+CS scaffolds as a function of scaffold location and 
implantation time 
For all pl ts n = 2 o
42, there were a remarkable number of blood vessels at the center of the EDC scaffold.  
All regions of the EDC+CS scaffolds showed evidence of blood vessels by Day 28.  By 
Day 42, there was a somewhat homogenous distribution of blood vessels within the 
EDC+CS scaffolds. 
Vessel densities for edge and core regions were plotted in Figure 28.  There was a 
general increasing trend for blood vessels in both edge and core regions for all scaffold 
types with increasing implantation time.  UnX scaffolds only showed blood vessels at the 
edge of the scaffold, whereas crosslinked vessels showed steadily increasing vessel 
densities throughout the scaffold.  The EDC+CS scaffolds showed higher vessel densities 
at both the edge and center compared to EDC scaffolds for most time points.  However, 
no blood vessels were seen at the center of the EDC+CS scaffolds at Day 42.  Both EDC 
and EDC+CS scaffolds showed a decrease in vessel density between Days 35 and 42. 
Figure 28: Core and edge vessel density 
Each point is an average of outer and middle 20% of scaffold (4 measurements per 
data point, n =2) 
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5.2.4 Void Area 
The void area fraction of each 
scaffold was measured to quantify the 
overall tissue ingrowth into the 
scaffolds.  Figure 29 shows the void 
area percentages for all scaffold types 
as a function of implantation time and 
scaffold location. 
All scaffolds show a decrease 
in the void fraction with increasing 
implantation time.  At early time 
points, void areas were lower at the 
edges of the scaffolds, compared to the 
central regions, with a fairly 
symmetrical profile.  At Days 28 and 
35, this profile had reversed itself in 
the EDC+CS scaffolds, with greater 
void areas at the edges. 
UnX scaffolds showed a 
reduced tendency to become filled and 
maintained a steeper gradient between 
the edges and central regions Figure 29: Void area fractions for UnX, EDC and 
EDC+CS scaffolds as a function of scaffold location 
and implantation time 
For all plots n = 2 
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compared to the crosslinked scaffolds, where the profile had flattened considerably even 
by Day 7. 
EDC+CS scaffolds reached a minimum void area by Day 28 in the central regions 
that persisted until Day 42.  EDC scaffolds only reached the same level by Day 42, 
whereas UnX scaffolds never reached this minimum. 
Figure 30 shows the void area fractions of the edge and core regions of the 
scaffolds as a function of scaffold type and implantation time.  This plot shows the same 
decreasing trend for all scaffold types at the edge and core regions.  UnX scaffolds have 
lower void fractions in the core regions compared to the core regions of crosslinked 
scaffolds, but they are never less than 20%.  The edges are likewise more filled.  Void 
fractions at the edge regions of EDC scaffolds increase slightly between Days 2 and 7, 
and remain unchanged until Day 14, before decreasing to levels similar to EDC+CS 
Figure 30: Core and edge void area fraction 
Each point is an average of outer and middle 20% of scaffold (4 measurements per 
data point, n = 2) 
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scaffolds.  EDC+CS scaffolds have a higher initial void fraction at Day 2 that persists 
through Day 14.  At later times, there is a marked decrease, particularly in the core region 
between Days 14 and 28.  After Day 28, there is little change in the void area, and there 
are only small differences between edge and core regions of the scaffolds. 
 61
5.3 MRI Correlations 
MRI measurements taken immediately before scaffolds were harvested were 
plotted against histology measurements of the same scaffolds in various combinations of 
parameters to explore the correlations between the two sets of data.  Scaffolds were only 
included if both MRI and histology data was available (21 scaffolds total).  Figure 31 
shows these results graphically and the statistical results are summarized in Table 2. 
Figure 31: Correlations between histology and MRI measurements 
Each point represents measurements taken from one scaffold, where the x-axis represents the MRI 
measurement and the y-axis represents the histology measurement.  A total of 21 scaffolds used for each 
scatter plot. 
The correlation between average cell density and average T2 values, (Figure 31A) 
shows longer T2 relaxation times are generally associated with lower cellular densities, 
and the correlation appears better at longer T2 values.  Void area and ADC are positively 
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correlated, as are void area and average T2 value.  The strongest correlation was seen 
between void area and T2 (Figure 31B). 
The Pearson product moment correlation for these combinations were computed.  
These results show that statistically significant (p < 0.05), linear relationships exist 
between T2 and cell density, ADC and cell density, T2 and void area, as well as ADC and 
void area (Table 2).  The best correlation is seen between void area and T2.  ADC and cell 
density have the weakest correlation. 
Table 2: Correlation statistics summary 
  MRI Parameter 
 n = 21 T2 ADC 
Cell Density r = -0.503 
p = 0.02 
r = -0.455 
p = 0.04 
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Void Area r = 0.666 
p < 0.0001 
r = 0.502 
p = 0.02 
 
To show the robustness of the linear regressions, plots of the residuals are shown 
in Figure 32 and were used to evaluate the quality of the fit.  Based on inspection, each 
shows a slight linear trend in the residuals.  This suggests that the model does not fit the 
data appropriately.  The residuals should be randomly distributed for a good fit.  The 
observations are plotted in order of increasing implantation time. 
 63
Figure 32: Residual values from correlations 
 
Difference between predicted and actual values for (A) Cell density and (B) Void area using T2, (C) Cell 
density and (D) Void area using ADC.  Long dash shows one standard deviation, short dash shows two 
standard deviations. 
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6 Discussion 
The goal of this study was to characterize the cellular response and remodeling 
processes that occur within collagen scaffolds after implantation and correlate these 
results with MRI measurements; working towards developing MRI methodologies that 
can be applied to noninvasively monitoring tissue responses to implants.  To study these 
relationships, the effects of crosslinking treatments and conjugation of GAG (CS) to 
collagen scaffolds were explored, as well as the in vitro degradation rates. 
6.1 In Vitro Scaffold Degradation 
The resistance of scaffolds to degradation, as measured by the amount of 
hydroxyproline solubilized when scaffolds were treated with bacterial collagenases, 
showed that the uncrosslinked scaffolds degraded faster than both crosslinked conditions.  
These observations are consistent with previous data on the effects of EDC crosslinking 
of collagen[22,32,82,83] and other materials.[25,84,85]  The addition of chemical bonds between 
collagen molecules increases the number of chain cleavages that must be performed by 
the enzyme to compromise the structural stability of the scaffold and liberate peptides.  
Despite the fact that EDC is a “zero-length” crosslinker and will only crosslink molecules 
that are within a few angstroms of each other, a sufficient numbers of bonds are formed 
to noticeably strengthen the material.  The EDC crosslinking reagent, 1-ethyl-(3,3-
dimethylaminopropyl)-carbodiimide, undergoes a reaction that effectively creates a 
peptide bond between two proteins.  This reaction would likely occur spontaneously 
under aqueous conditions, but at a much slower rate. 
Unexpectedly, there was no detectable difference in the degradation between the 
EDC and EDC+CS scaffolds.  The fact that the crosslinker itself is consumed in 
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conjugating the chondroitin sulfate to the collagen matrix, should reduce the number of 
available reaction sites to crosslink collagen molecules.  Previous research has indicated 
that this is indeed the case and lower resistances to degradation are obtained when CS 
was incorporated, but this was not a statistically significant difference.[86]  In a separate 
study, a secondary crosslinking step attached the CS, after first crosslinking the collagen 
matrix itself.[26]  This resulted in collagen-CS matrices that were more resistant to 
degradation than matrices crosslinked once with EDC alone. 
6.2 Histological analysis 
6.2.1 Thickness 
Scaffold thicknesses generally showed a decreasing trend with increasing 
implantation time regardless of crosslinking technique.  This result is consistent the 
expected outcomes.  The wound environment created by the surgery and the associated 
inflammatory response to both the surgery and the foreign material, as well as the 
continuous remodeling processes that occur within the rat once the inflammation has 
resolved, all involve the release of proteolytic enzymes that serve to degrade the collagen 
scaffolds.[10]  The initial inflammatory response, minutes to hours after the scaffold has 
been implanted, involves the release of non-specific lysosomal proteases and oxygen-
derived free radicals from damaged cells and neutrophils that degrade most protein 
materials, including potentially infectious microbes.  Later in the inflammatory response, 
macrophages secrete neutral proteases that further degrade the scaffold.[87]  After the 
inflammatory response, normal tissue remodeling processes involving the regulation of 
very specific matrix metalloproteinases (MMP) by tissue inhibitors of metalloproteinase 
(TIMP), cause the decrease in scaffold size.  Collagenase MMPs, such as MMP-1,-8,-
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13,and -18 have all been show to act on collagen substrates to breakdown these 
proteins.[88]  While these enzymes are very substrate specific, the structural homology of 
collagen types between species allows the native rats enzymes to still use the bovine 
collagen as a substrate.  Overall, the degradation rates appeared to be slightly faster 
compared to Pieper et al., the where the scaffolds were still present after 10 weeks.[37]
The scaffold thicknesses, even at Day 2, were greatly reduced from the initial 
thickness of approximately 1 cm.  This is primarily due to the compressive forces placed 
on the scaffold by the surrounding tissue, namely the skin.  The compressive modulus of 
these materials is very low and has been reported to be on the order of 1kPa and 150Pa 
for EDC+CS and uncrosslinked scaffolds, respectively.[29]  The presence of CS was also 
associated with a slight increase in thickness.  This can be explained by the fact that 
hydrophilic charge groups on the surfaces of the GAG are responsible for increased water 
content in cartilage based on the electrostatic forces that cause water molecules to arrange 
in shells around the long GAG chains.[89]  These same electrostatic forces would lead to a 
slight swelling of EDC+CS scaffolds compared to EDC  and uncrosslinked scaffolds. 
The thicknesses of the capsules surrounding UnX scaffolds were usually much 
thicker than those surrounding the crosslinked scaffolds.  This is thought to be due to the 
increased release rate of protein fragments over the crosslinked scaffolds that the 
inflammatory cells respond to that increases the cellular activity to isolate the implant.[87]  
Furthermore, crosslinking has been shown to reduce the immunogenicity of collagen, [7] 
which may also be a contributing factor at time points after 2 days. 
The MRI measurements of crosslinked scaffolds indicated an increase in volumes 
for all scaffold types at Day 7.  This is consistent with the thickness measurements in this 
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study.  At Day 14, the crosslinked scaffolds had returned to values close to their initial 
volume, and showed a decreasing trend at later time points.  The same decrease was 
observed in the scaffold thicknesses of the crosslinked sponges, except for scaffolds 
harvested at Day 42.  EDC+CS scaffolds were generally thicker than EDC at all time 
points except Day 2, however, EDC scaffold volumes were higher than EDC+CS.  The 
thickness measurements are also influenced by the various processing steps (fixing, 
embedding, sectioning) that the scaffolds go through before they are placed under the 
microscope.  Sectioning artifacts, such as separation of tissue layers or compression, may 
also have added variability to the data. 
6.2.2 Cellular Density 
Cellular density within the scaffolds was measured as a function of location with 
the scaffold by counting the number of nuclei present within ROIs.  The uncrosslinked 
scaffolds showed greater cell density at the edges of the scaffold than the crosslinked 
scaffolds at the three time points they were harvested (2, 7, and 14 days).  This result is 
thought to be part of the same increased inflammatory response that contributed to a 
thicker capsule.  Pieper et al. also reported a decrease in cell density for crosslinked 
scaffolds between 2 and 4 weeks that was not observed in this study.[37]  A qualitative 
change was observed in the predominant cell type present in the crosslinked scaffolds, 
from inflammatory cells to fibroblasts with increasing implantation time.  The change in 
the cell population is expected to reduce the total cellularity, but this was not observed. 
Cellular migration into the scaffolds and the establishment of a homogenous cell 
population occurred in the EDC+CS scaffolds sooner than in the EDC.  These results are 
consistent with other reports of improved tissue ingrowth and cellular response of 
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collagen-GAG matrices over unmodified collagen.[33,34,90-92]  The cells also had further to 
infiltrate as the EDC+CS were slightly thicker, at all time points.  The exact mechanism 
by which CS improves cellular infiltration is still not clear.  Explanations include the 
binding of CS to a wide range of proteins (proteases, growth factors, other ECM 
components, morphogens); either sequestering them or presenting them to the cells, 
resulting in changes of cell behavior.[35]  The variations in GAG structure and the 
multitude of proteins with which they interact make their full characterization difficult.  
The binding of CS to basic fibroblast growth factor (bFGF) has been shown to play a role 
in the binding of bFGF to the surface receptors on the cell surface that actually lead to a 
change in cell function.[93]  This could be occurring with any number of endogenous 
growth factors.  As a natural part of the normal ECM, it is expected that cell function and 
biocompatibility would be improved by the presence of CS. 
The metric for cellular density used in this study is based on total cellularity and 
does not take into consideration the type of cell present.  The population sizes of 
neutrophils, macrophages, leukocytes, giant cells and fibroblasts, as well as the relative 
numbers of each type of cell, are considered important when evaluating the overall 
biocompatibility of a material.[39]  However, for the purposes of this study, total cell 
populations are considered suitable because conventional MRI is not able to distinguish 
differences in cell population.  There has been some investigation into using 1H NMR 
spectroscopy to distinguish between types of cells based on differences in cell 
metabolites, but this work is beyond the scope of this thesis.[94]
MRI measurements of T2 values of the scaffold showed regions of short and long 
T2 at Days 2, 7, and 14 for all scaffolds.  The long T2 values, observed in the core regions 
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of the scaffolds, gradually decreased with implantation time until they were 
indistinguishable from the short T2 regions.  This is consistent with cellular infiltration 
and tissue ingrowth into the scaffolds and the establishment of a homogenous cell 
population.  The average T2 values for all scaffolds decreased until Day 21, at later time 
points they remain relatively constant.  ADC measurements showed a similar decrease up 
to Day 21, and then remained constant at later time points, corroborating the T2 
observations. 
6.2.3 Blood Vessel Density 
EDC+CS scaffolds showed the greatest development of a vascular network, and 
had the greatest vessel density at the end of the study.  These observations are consistent 
with expected results and previous reports of improved angiogenesis in the literature 
when chondroitin sulfate or other GAGs are present.[37,95,96]  The increased number of 
blood vessels at the margins of UnX scaffolds was associated with elevated cell densities.  
The angiogenic potential of uncrosslinked collagen scaffolds, while slightly greater at the 
edges than crosslinked sponges, is not particularly remarkable given its instability and 
compared to what can be achieved by various modifications, such as the incorporation of 
growth factors[97].  The higher cell densities result in the release various chemotractants 
and cytokines at greater levels than other scaffolds, leading to the establishment of a 
vascular network.  However, the scaffold degraded before this process was complete, and 
angiogenesis was not observed in the core regions of these scaffolds. 
Following the same trend as cell density, the blood vessel density generally 
increased with implantation time, and progressed from the margins towards the center of 
the scaffold.  Pieper et al. also observed the steady increase in the number of blood 
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vessels,[37] except between 4 and 10 weeks, where they observed a decrease in the 
number of blood vessels.  These scaffolds were not harvested at 10 weeks, but a decrease 
in vessel density was seen at both the edge and core region of the crosslinked scaffolds, 
between Days 35 and 42.  This may be explained in part by an increase in vessel size as 
they become more mature within the implant.  Tiny capillaries eventually remodel to 
create larger vessels, reducing the total number of vessels, but not the amount of blood 
delivered.  As blood vessels were measured here, no consideration was given to the size 
of the vessels. 
The methods used to count blood vessels and generate data regarding the 
angiogenesis within the scaffolds, while it was applied consistently to allow comparisons 
between scaffold types, is not consistent with densities achieved in other collagen based 
implants.  Generally, the results shown here are much lower than what has been 
previously reported for similar implants.[95,98]  This may in part have to do with the 
detection method used to identify blood vessels.  The shape and size of blood vessels 
vary greatly, and the actual shape observed in the microscope slide is further altered by 
the relative orientation of the vessel to the sectioning plane.  Other studies have 
sometimes used immunohistochemistry to positively identify certain proteins that are 
found only within blood vessels, such as collagen-IV, CD31, or von Willebrand factor.[44]  
This would remove the dependence of the measurement on the shape and size of the 
vessel.  While this has probably led to an underestimation of the total vascularity of these 
implants, the changes in blood vessel density and the relative amounts are accurate. 
MRI measurements of blood flow in the scaffolds were performed using serial 
contrast-enhanced MRI to measure the time to maximum enhancement (time-to-peak, 
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TTP) and the time for the maximum enhancement to decrease to half of its peak value 
(T1/2).  These results showed that blood flow in the center of the scaffolds increased with 
increasing implantation time, consistent with the observed increase in vessel density.  
Crosslinked scaffolds had longer TTP and T1/2 values than uncrosslinked scaffolds, 
suggesting reduced flow and lower blood vessel densities, opposite to the histology 
observations.  However, these MRI measurements do not account for the shorter 
diffusion distances in the uncrosslinked scaffolds, due to their smaller size, which may 
explain this discrepancy. 
6.2.4 Void Area 
The void area of all scaffolds was found to decrease with postoperative time.  
This finding is consistent with expected results and previous studies that have shown 
collagen implants to gradually be filled with natural tissue.[10]  However, the correlation 
between tissue ingrowth and void area is not seen in the literature to the best of the 
author’s knowledge.  Void area measurements may be considered the inverse of tissue 
ingrowth, except for the scaffold material present in the ROI.  The implants are initially 
very porous (>90%)[15] and as they are remodeled and incorporated into the subcutaneous 
fascia, these pores are filled by the deposition of new ECM, angiogenesis and increasing 
cellular densities.  The degradation of the implant also leads the breakdown of struts that 
maintain the individual pore volumes as the scaffold is remodeled. 
EDC+CS scaffolds were completely filled with ECM and cells by Day 28, while 
the EDC scaffolds only showed similar filling by Day 35 and UnX scaffolds did not fill 
completely by Day 14.  According to Pieper et al, the EDC+CS scaffolds still maintained 
their open porous structure at 10 weeks.  This discrepancy could be due to a number of 
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factors.  One possible explanation could be that the rats used in this study were much 
younger and their higher metabolisms/growth impacted the remodeling process. 
A reversal in the gradient direction in crosslinked scaffolds, from low-to-high to 
high-to-low, when comparing edge to core void areas at early and late time points, 
respectively, is in part due to the initial formation of a dense capsule that is eventually 
remodeled during the tissue integration process.  The final densities at the center of the 
crosslinked scaffolds were greater than the density of normal, homeostatic tissue. 
These results for void areas are consistent with the measurements of cellular 
densities and blood vessels, which all capture different aspects of the remodeling process.  
The consistency between all three measurements provides strong evidence supporting the 
conclusion that better tissue response and ingrowth is observed in the EDC+CS scaffolds 
compared to the other two conditions. 
T2 and ADC measurements of the crosslinked scaffolds remained relatively 
constant at time points after 21 days, as observed in the void area measurements, showing 
good agreement between the two analysis modalities.  Uncrosslinked scaffolds generally 
have lower void areas than crosslinked scaffolds, which was reflected in the lower ADC 
and T2 values of these scaffolds. 
6.3 MRI Correlations 
The correlations between histology measurements of cellular density, void area, 
and scaffold thickness against MRI measurements of T2, ADC, and scaffold volume show 
that there is a relationship between the two analysis modalities.  The strongest correlation 
was seen between the average void areas and water T2 relaxation times.  This result 
makes sense, given that the T2 value depends heavily on the ratio between free (bulk) 
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water molecules and bound water molecules.  The binding of water to soluble proteins, 
cell membranes, and structural proteins all reduce the measured T2 value.  The void area 
is directly related to the amount of material available to bind water. 
Attempts to use multiple linear regressions were unsuccessful.  Presumably, using 
more than one MRI parameter to predict a histological measurement may give a better 
result as changes in the physiological state would influence all MRI parameters to some 
extent.  However, the MRI parameters themselves are usually highly correlated.  For 
example, short T2 values are usually associated with slow ADC values.  When 
performing multiple linear regressions, it is necessary to have no relationships between 
the independent variables.  The slight linear trend in the residual values suggests that 
there is some dependence on implantation time that is not accounted for, or that a simple 
linear regression is not the most appropriate model.  However, previous studies 
documenting the relationship between cellular density and ADC have used simple linear 
regressions.[73,74]
The relationship between total cellularity, T2, and ADC values has been well 
documented in the literature.[72-74,99,100]  Based on these previous results, it is expected 
that the correlations between the histological and MRI data in our study would be 
stronger.  For example, one study reported a correlation coefficient of r = -0.71 between 
cell density and ADC in tumors. [74]  In the present study, the differences in spatial 
resolution between the two analysis modalities may have also contributed to the weak 
correlations.  The histological sections were five micrometers in thickness, whereas each 
MRI slice was one millimeter thick.  This resulted in under-sampled histology data 
relative to the MRI data; which analyzed and averaged the whole volume of the scaffold.  
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While the scaffolds are assumed to be relatively homogenous in the direction 
perpendicular to the plane of the images, particularly in the central regions, this was not 
verified using multiple histology slices.  Future studies should increase the number of 
histological sections analyzed per MRI slice to better correlate that data distributions 
associated with the sampling frequencies. 
These correlations would also be improved by better co-registering the two data 
sets.  This histological analysis samples a narrow region from the central MRI slice for 
each scaffold.  Instead of comparing an average cellular density, computed by averaging 
across the thickness of a section, to an average T2 value taken over the entire scaffold, it 
would be better to compare just the central region of an MRI slice with the histology 
section analyzed.  The measurements from the binned histology regions could be 
averaged to cover the same spatial distance as an MR image pixel.  Comparisons could 
then be made on a pixel by pixel basis.  This would account for heterogeneity across the 
thickness of the scaffold and lead to better correlations. 
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7 Future Work 
The statistically significant correlations between that two analysis modalities 
show that MRI can be used to faithfully monitor the remodeling of collagen scaffolds.  
The conclusions drawn from this study would be greatly strengthened by repeating the 
experiments to obtain independent histology samples at each time point.  The differential 
tissue responses would be confirmed and the differences between the scaffolds can be 
statistically confirmed.  This would also create a more complete histology dataset for 
more accurate correlations with the MRI dataset.  Furthermore, using 
immunohistochemistry to positively identify blood vessels will lead to a more accurate 
measurement of the vascularity of the implants. 
The differential tissue responses that were obtained by the various crosslinking 
treatments and conjugation of chondroitin sulfate to the scaffold could be further widened 
by implanting scaffolds with other treatments.  Changing the GAG used to heparin sulfate 
or some other GAG would produce varying cellular responses.  The incorporation of 
growth factors, such as bFGF[101] and VEGF[102] has also been shown to greatly alter the 
tissue response.  These would both allow further histology and MRI data to be collected 
for correlations, advancing the understanding of how the two analysis modalities relate to 
each other. 
The void area correlates well with T2 values, however, in terms of physiology, 
void area is not a commonly used metric.  Usually, total collagen content or new collagen 
deposition is measured in scaffolds to determine how well the implant is integrating with 
the host tissue.  Using immunohistochemistry to stain for specific types of rat collagen 
(types I and III) within the bovine collagen scaffold will provide more data about how the 
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cells are responding.  Large amounts of new collagen synthesis would suggest greater 
biocompatibility and a favorable cellular response.  Related to this, bovine collagen 
antibodies would provide a better metric for scaffold degradation.  Measuring the 
changes in actual material is better than measuring the size when multiple processes 
occur within that space. 
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8 Summary 
This study has characterized the varying tissue responses observed when collagen 
scaffolds, crosslinked with EDC alone or in the presence of chondroitin sulfate, are 
implanted into dorsal subcutaneous pockets of rats and these data are correlated with 
MRI assessments of the scaffolds.  The improved biostability of crosslinked scaffolds led 
to greater persistence of these scaffolds compared to uncrosslinked scaffolds.  The 
addition of CS further increased the biostability of the scaffold.  Greatest cellular density 
was observed in uncrosslinked scaffolds at Day 14.  Crosslinked scaffolds took longer to 
populate with cells, and reach similar cellular densities after 35 days.  An increased 
inflammatory response was thought to contribute to the greater cellular densities in 
uncrosslinked scaffolds, and was associated with a thicker capsule surrounding the 
implants.  Measurements of blood vessel density showed the establishment of a vascular 
network within the EDC+CS scaffolds at 28 days and 35 days for the EDC scaffolds; 
indicating faster integration with the surrounding tissue is achieved by conjugating CS to 
the collagen scaffolds.  The void area observations showed scaffold pores were gradually 
filled by new ECM deposition.  EDC+CS scaffolds filled before the EDC scaffolds; again 
showing faster integration.  Uncrosslinked scaffolds did not fill with ECM and blood 
vessels as completely as the crosslinked scaffolds.  These observations are based on a 
limited number of samples, and care should be taken interpreting these data. 
Correlations between the MRI and histology measurements showed that 
relationships existed between cell density and T2 and ADC, and between void area and T2 
and ADC.  The strongest correlation was observed between void area and T2.  These 
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results demonstrate that MRI is sensitive to physiological changes that occur during the 
remodeling of collagen implants. 
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10 Appendices 
These appendices contain the ImageJ code that was used to consistently count cells 
and measure the void area fractions. 
10.1 Cellular Density 
macro "Cell Count [f5]"{ 
 run("HSB Stack Splitter"); 
 run("Subtract Background...", "rolling=50 white"); 
 run("Enhance Contrast", "saturated=0.5"); 
 run("Apply LUT"); 
 //run("Threshold..."); 
 setThreshold(0, 150); 
 run("Convert to Mask"); 
 run("Watershed"); 
 run("Analyze Particles...", "size=5-200 circularity=0.40-1.00 
show=Outlines display exclude summarize"); 
} 
10.2 Void Area 
macro "Void Fraction [f7]"{ 
 run("HSB Stack Splitter"); 
 run("Subtract Background...", "rolling=50 white"); 
 //run("Threshold..."); 
 setThreshold(250, 255); 
 run("Convert to Mask"); 
 run("Measure"); 
} 
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